S&P 500   4,286.76 (-0.03%)
DOW   33,403.12 (-0.31%)
QQQ   359.97 (+0.47%)
AAPL   173.04 (+1.07%)
MSFT   317.43 (+0.53%)
META   304.82 (+1.54%)
GOOGL   132.80 (+1.48%)
AMZN   128.21 (+0.86%)
TSLA   246.06 (-1.66%)
NVDA   446.38 (+2.62%)
NIO   8.80 (-2.65%)
BABA   86.27 (-0.54%)
AMD   103.31 (+0.48%)
T   14.95 (-0.47%)
F   12.38 (-0.32%)
MU   68.77 (+1.09%)
CGC   0.77 (-1.70%)
GE   110.18 (-0.33%)
DIS   80.91 (-0.17%)
AMC   8.33 (+4.26%)
PFE   33.37 (+0.60%)
PYPL   59.25 (+1.35%)
NFLX   380.49 (+0.77%)
S&P 500   4,286.76 (-0.03%)
DOW   33,403.12 (-0.31%)
QQQ   359.97 (+0.47%)
AAPL   173.04 (+1.07%)
MSFT   317.43 (+0.53%)
META   304.82 (+1.54%)
GOOGL   132.80 (+1.48%)
AMZN   128.21 (+0.86%)
TSLA   246.06 (-1.66%)
NVDA   446.38 (+2.62%)
NIO   8.80 (-2.65%)
BABA   86.27 (-0.54%)
AMD   103.31 (+0.48%)
T   14.95 (-0.47%)
F   12.38 (-0.32%)
MU   68.77 (+1.09%)
CGC   0.77 (-1.70%)
GE   110.18 (-0.33%)
DIS   80.91 (-0.17%)
AMC   8.33 (+4.26%)
PFE   33.37 (+0.60%)
PYPL   59.25 (+1.35%)
NFLX   380.49 (+0.77%)
S&P 500   4,286.76 (-0.03%)
DOW   33,403.12 (-0.31%)
QQQ   359.97 (+0.47%)
AAPL   173.04 (+1.07%)
MSFT   317.43 (+0.53%)
META   304.82 (+1.54%)
GOOGL   132.80 (+1.48%)
AMZN   128.21 (+0.86%)
TSLA   246.06 (-1.66%)
NVDA   446.38 (+2.62%)
NIO   8.80 (-2.65%)
BABA   86.27 (-0.54%)
AMD   103.31 (+0.48%)
T   14.95 (-0.47%)
F   12.38 (-0.32%)
MU   68.77 (+1.09%)
CGC   0.77 (-1.70%)
GE   110.18 (-0.33%)
DIS   80.91 (-0.17%)
AMC   8.33 (+4.26%)
PFE   33.37 (+0.60%)
PYPL   59.25 (+1.35%)
NFLX   380.49 (+0.77%)
S&P 500   4,286.76 (-0.03%)
DOW   33,403.12 (-0.31%)
QQQ   359.97 (+0.47%)
AAPL   173.04 (+1.07%)
MSFT   317.43 (+0.53%)
META   304.82 (+1.54%)
GOOGL   132.80 (+1.48%)
AMZN   128.21 (+0.86%)
TSLA   246.06 (-1.66%)
NVDA   446.38 (+2.62%)
NIO   8.80 (-2.65%)
BABA   86.27 (-0.54%)
AMD   103.31 (+0.48%)
T   14.95 (-0.47%)
F   12.38 (-0.32%)
MU   68.77 (+1.09%)
CGC   0.77 (-1.70%)
GE   110.18 (-0.33%)
DIS   80.91 (-0.17%)
AMC   8.33 (+4.26%)
PFE   33.37 (+0.60%)
PYPL   59.25 (+1.35%)
NFLX   380.49 (+0.77%)
NASDAQ:ITCI

Intra-Cellular Therapies (ITCI) SEC Filings & 10K Form

$52.44
+0.35 (+0.67%)
(As of 09:58 AM ET)
Compare
Today's Range
$51.69
▼
$52.57
50-Day Range
$52.09
▼
$61.96
52-Week Range
$42.01
▼
$67.05
Volume
78,897 shs
Average Volume
721,516 shs
Market Capitalization
$5.03 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$78.78
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Recent Intra-Cellular Therapies SEC Filings

Export to Excel
DateFilerForm TypeView
09/19/2023
7:40 PM		Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2023
3:13 PM		Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2023
3:13 PM		Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2023
3:18 PM		Alexandria Venture Investments, LLC (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
3:40 PM		Alexandria Venture Investments, LLC (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2023
5:05 PM		Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2023
5:09 PM		Intra-Cellular Therapies (Subject)
Neumann Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/03/2023
6:39 AM		Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2023
6:44 AM		Intra-Cellular Therapies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/20/2023
4:47 PM		Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2023
3:13 PM		Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/07/2023
5:07 PM		Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4/A
07/07/2023
5:07 PM		Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4/A
07/07/2023
5:08 PM		Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4/A
07/05/2023
3:30 PM		Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
3:30 PM		Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
4:11 PM		Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
4:11 PM		Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
4:12 PM		Intra-Cellular Therapies (Issuer)
Salas Eduardo Rene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
4:12 PM		Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
4:05 PM		Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
3:28 PM		Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/04/2023
6:45 AM		Intra-Cellular Therapies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/04/2023
6:37 AM		Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2023
5:00 PM		Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2023
6:12 AM		Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2023
6:31 PM		Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2023
6:32 PM		Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2023
6:34 PM		Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2023
6:35 PM		Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2023
6:36 PM		Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2023
6:54 PM		Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2023
6:49 PM		Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2023
6:50 PM		Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2023
6:51 PM		Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2023
6:52 PM		Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2023
6:03 PM		Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2023
6:46 AM		Intra-Cellular Therapies (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/01/2023
6:41 AM		Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2023
6:59 PM		Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2023
7:00 PM		Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2023
7:01 PM		Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2023
7:02 PM		Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2023
7:03 PM		Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2023
7:01 PM		Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2023
7:02 PM		Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2023
7:03 PM		Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2023
7:04 PM		Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2023
7:05 PM		Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2023
10:22 AM		Intra-Cellular Therapies (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
01/10/2023
1:38 PM		Intra-Cellular Therapies (Subject)
WASATCH ADVISORS INC (Filed by)
Form SC 13G/A
01/09/2023
4:13 PM		Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2023
3:18 PM		Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2023
3:19 PM		Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2022
3:09 PM		Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/21/2022
3:06 PM		Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2022
6:01 PM		Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2022
6:14 PM		Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2022
6:46 AM		Intra-Cellular Therapies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/03/2022
6:35 AM		Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/05/2022
3:04 PM		Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2022
3:11 PM		Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies:
SEC Filings Tools:
This page (NASDAQ:ITCI) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -